Inventor · disambiguated record
Robert Dally
Also filed as: DALLY ROBERT · DALLY ROBERT D · DALLY ROBERT DEAN
15 granted patents·10 pending applications·265 citations·filing 1995–2019
93Inventor score
Top patents by PatentIndex Score
25 records- 0196US6187799B1Inhibition of raf kinase activity using aryl ureasONYX PHARMACEUTICALS·Filed 1998·Granted Feb 13, 2001·118 cites·18 claims
- 0292US9156824B2CDC7 inhibitorsLILLY CO ELI·Filed 2014·Granted Oct 13, 2015·23 cites·32 claims
- 0387US8217032B2Selective estrogen receptor modulators for the treatment of vasomotor symptomsDALLY ROBERT DEAN·Filed 2011·Granted Jul 10, 2012·15 cites·14 claims
- 0486US6660752B22,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonistsBAYER PHARMACEUTICALS CORP·Filed 2002·Granted Dec 9, 2003·24 cites·30 claims
- 0583US6353006B1Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agentsBAYER AG·Filed 1999·Granted Mar 5, 2002·33 cites·7 claims
- 0682US7745438B23-(2-acylamino-1-hydroxyethyl)-morpholine derivatives and their use as bace inhibitorsLILLY CO ELI·Filed 2005·Granted Jun 29, 2010·8 cites·4 claims
- 0775US7320995B2Benzimidazoles and benzothiazoles as inhibitors of map kinaseLILLY CO ELI·Filed 2003·Granted Jan 22, 2008·12 cites·9 claims
- 0873US8148387B2AKT and P70 S6 kinase inhibitorsSHEPHERD TIMOTHY ALAN·Filed 2009·Granted Apr 3, 2012·3 cites·17 claims
- 0967US2010063088A1Raf Kinase InhibitorsWOOD JILL E·Filed 2009·Application pending·0 cites
- 1066US6919371B22,6-substituted chroman derivatives useful as beta-3 adrenoreceptor agonistsBAYER PHARMACEUTICALS CORP·Filed 2003·Granted Jul 19, 2005·2 cites·24 claims
- 1162US5686469AAminomethylene derivaties as immunosuppressantsMILES INC·Filed 1995·Granted Nov 11, 1997·10 cites·35 claims
- 1260US2012178780A1Raf kinase inhibitorsWOOD JILL E·Filed 2012·Application pending·0 cites
- 1359US5633277ASulfonamide aminomethylene derivatives as immunosuppressantsMILES INC·Filed 1995·Granted May 27, 1997·17 cites·12 claims
- 1459US2005256174A1Raf kinase inhibitorsWOOD JILL E·Filed 2005·Application pending·0 cites
- 1556US11028074B2CD73 inhibitorsLILLY CO ELI·Filed 2019·Granted Jun 8, 2021·0 cites·22 claims
- 1654US7585977B2Selective estrogen receptor modulators containing a phenylsulfonyl groupLILLY CO ELI·Filed 2008·Granted Sep 8, 2009·0 cites·18 claims
- 1753US2005215594A12,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonistsBAYER PHARMACEUTICALS CORP·Filed 2005·Application pending·0 cites
- 1849US2009023917A1Selective Estrogen Receptor Modulators for the Treatment of Vasomotor SymptomsLILLY CO ELI·Filed 2005·Application pending·0 cites
- 1947US2001006975A1Raf kinase inhibitorsBAYER CORP AND ONYX PHARMACEUT·Filed 2001·Application pending·0 cites
- 2044US2012071490A1P70 s6 kinase inhibitorsDALLY ROBERT DEAN·Filed 2011·Application pending·0 cites
- 2143US2007111988A1Selective estrogen receptor modulatorsLILLY CO ELI·Filed 2005·Application pending·0 cites
- 2241US2003207865A1Substituted 2-arylimino heterocycles and compositions containing them for use as progesterone receptor binding agentsFiled 2001·Application pending·0 cites
- 2340US7863310B2Kinase inhibitorsLILLY CO ELI·Filed 2005·Granted Jan 4, 2011·0 cites·5 claims
- 2437US9776992B21-oxo-1,2-dihydroisoquinolin-7-yl-(5-substituted-thiophen-2-yl)-sulfonamide compounds, formulations containing those compounds, and their use as AICARFT inhibitors in the treatment of cancersLILLY CO ELI·Filed 2015·Granted Oct 3, 2017·0 cites·8 claims
- 2537US2003229072A1Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binning agentsFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Robert Dally files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →